DexCom (NASDAQ: DXCM) releases its next round of earnings this Wednesday, May 1. Get the latest predictions in Benzinga's essential guide to the company's first-quarter earnings report.
Earnings and Revenue
Wall Street analysts see DexCom reporting a quarterly loss of 16 cents per share on sales of $246.39 million.
In the same quarter last year, DexCom reported an EPS loss of 32 cents on revenue of $184.4 million. Sales would be up 33.62 percent from the same quarter last year. Here's how the company's reported EPS has compared to analyst estimates in the past:
|Quarter||Q4 2018||Q3 2018||Q2 2018||Q1 2018||Q4 2017|
Over the last 52-week period, shares are up 65.44 percent. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Analyst estimates have adjusted higher for EPS and revenues over the past 90 days. The most common rating from analysts on DexCom stock is a Neutral. The strength of this rating has maintained conviction over the past three months.
DexCom's conference call is scheduled to begin at 4:30 p.m. ET and can be accessed here: https://www.dexcom.com/en-IN
See more from Benzinga
- Q1 Earnings Preview For FreightCar America
- The Habit Restaurants Q1 Earnings Preview
- Prudential Financial Q1 Earnings Preview
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.